Back to Journals » Therapeutics and Clinical Risk Management » Volume 1 » Issue 2
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 1, 2005
Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence
David RP Guay
Therapeutics and Clinical Risk Management 2005, 1:157-166
Published Date: 15 July 2005
Clinical implications of changes in hepatic drug metabolism in older people
Sarah N Hilmer, Gillian M Shenfield, David G Le Couteur
Therapeutics and Clinical Risk Management 2005, 1:151-156
Published Date: 15 July 2005
Renal replacement therapy in the intensive care unit
Neesh Pannu, RT Noel Gibney
Therapeutics and Clinical Risk Management 2005, 1:141-150
Published Date: 15 July 2005
The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?
Deanna L McDanel, Barbara A Muller
Therapeutics and Clinical Risk Management 2005, 1:125-140
Published Date: 15 July 2005
Risk factors of allergic rhinitis: genetic or environmental?
De-Yun Wang
Therapeutics and Clinical Risk Management 2005, 1:115-123
Published Date: 15 July 2005
Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy
Charity D Scripture, William D Figg, Alex Sparreboom
Therapeutics and Clinical Risk Management 2005, 1:107-114
Published Date: 15 July 2005
A review of studies of adherence with antihypertensive drugs using prescription databases
Nicola Fitz-Simon, Kathleen Bennett, John Feely
Therapeutics and Clinical Risk Management 2005, 1:93-106
Published Date: 15 July 2005
The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma
Graeme P Currie, Tom C Fardon, Daniel KC Lee
Therapeutics and Clinical Risk Management 2005, 1:83-92
Published Date: 15 July 2005
The controversy surrounding OxyContin abuse: issues and solutions
Sujata S Jayawant, Rajesh Balkrishnan
Therapeutics and Clinical Risk Management 2005, 1:77-82
Published Date: 15 July 2005